Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 14 Mar 2022  |  North America

    Next-generation Diagnostics Outlook, 2022

    Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth

    In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...

  2. 08 Mar 2022  |  North America

    Global Pharmaceuticals Outlook, 2022

    The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders

    Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-bei...

  3. 01 Mar 2022  |  Europe

    European Clinical Laboratory Services Growth Opportunity

    Customer Experience Driven by New B2B and B2C Business Models

    Diagnostics is the backbone of the healthcare sector. According to a World Health Organization (WHO) study, although the segment accounts for less than 5% of hospital costs, its findings influence 60–70% of healthcare decision-making. Diagnostics helps to analyze medical conditions and guide patients toward the right medication, treatment, or sur...

  4. 28 Feb 2022  |  North America

    United States Clinical Laboratory Services Growth Opportunities

    Advanced Molecular Diagnostics and At-Home Testing are Growth Prerequisites

    The United States spends more than $3 trillion—nearly 18% of GDP—on healthcare, a massive sector. Healthcare value chain participants face dynamic environments that several trends impact, including the rise in the aging population (16.9% in 2020); chronic disease burden; regulatory challenges; integration across the care continuum; migration to...

  5. 22 Feb 2022  |  North America

    United States Liquid Biopsy Growth Opportunities

    Non-invasive Liquid Biopsy Technology Shapes the Precision Diagnostics Landscape

    Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio. Advances in next-generation sequencing-based companion diagnosti...

  6. 15 Feb 2022  |  North America

    Global Biologics Contract Development and Manufacturing Organization Profiles and Growth Opportunities

    The Contract Research, Development, and Manufacturing Organization Business Model to Drive Future Growth Potential

    Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...

  7. 17 Jan 2022  |  Global

    Global Advances in Omics Technologies Enable Future Drug Discovery and Growth Opportunities

    Emerging Omics Platforms Drive Precision Drug Discovery

    For a long time, drug discovery followed the same path and used conventional analysis methods for proposed targets. Today, changes in technology and the ability to study omics are transforming drug development. Personalized therapy is on the rise and promises to be more effective and efficient in addressing challenges. With growing interest in ...

  8. 02 Dec 2021  |  North America

    Global Pharmaceutical Industry Growth Opportunities

    2021 Highlights and What to Expect in 2022

    The global pharmaceutical industry is witnessing dynamic trends following the coronavirus pandemic and is adapting to new challenges and opportunities. This study analyzes the 2021 highlights in the global pharmaceutical industry and provides forecasts for the next year and beyond. It addresses the impact of innovative modalities, technologies, ...

  9. 30 Nov 2021  |  Global

    Targeted Immunotherapy in Oncology

    Developments in Biotechnology Platforms Leading to Increasing Immuno-oncology Applications

    This research service investigates technologies that propel the development of new targeted immunotherapies, particularly those that deliver therapeutic DNA and proteins. The top 3 growth opportunities focus on enhanced gene delivery systems for greater precision, the support of such systems through novel biotech platforms, and the affordability of...

  10. 26 Nov 2021  |  Europe

    EU COVID-19 Vaccine and Therapeutics Insights, Trends, and Growth Opportunities

    Future Growth Potential Driven by Capabilities and Expertise in Vaccine Manufacturing

    With this research service, Frost & Sullivan’s Healthcare and Life Sciences team provides critical insights into the European Union and UK COVID-19 vaccine and therapeutics market. The report analyzes COVID-19 vaccines and therapeutics in development and delves into supply chain considerations and requirements to manage distribution. Importantly,...